BRPI0817310A2 - Ensaio de monitoramento de fármaco - Google Patents

Ensaio de monitoramento de fármaco

Info

Publication number
BRPI0817310A2
BRPI0817310A2 BRPI0817310A BRPI0817310A2 BR PI0817310 A2 BRPI0817310 A2 BR PI0817310A2 BR PI0817310 A BRPI0817310 A BR PI0817310A BR PI0817310 A2 BRPI0817310 A2 BR PI0817310A2
Authority
BR
Brazil
Prior art keywords
drug monitoring
monitoring assay
assay
drug
monitoring
Prior art date
Application number
Other languages
English (en)
Inventor
Patrick Albientz
Jean-Miche Grenet
Rainer Hillebrand
François Legay
Peter Marbach
Séverine Marrony
Judith Schaefer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0817310A2 publication Critical patent/BRPI0817310A2/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0817310 2007-09-27 2008-09-26 Ensaio de monitoramento de fármaco BRPI0817310A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07117444 2007-09-27
PCT/EP2008/062891 WO2009040409A1 (en) 2007-09-27 2008-09-26 Drug monitoring assay

Publications (1)

Publication Number Publication Date
BRPI0817310A2 true BRPI0817310A2 (pt) 2015-03-17

Family

ID=38715157

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0817310 BRPI0817310A2 (pt) 2007-09-27 2008-09-26 Ensaio de monitoramento de fármaco

Country Status (11)

Country Link
US (2) US8076160B2 (pt)
EP (1) EP2198309A1 (pt)
JP (1) JP2010540920A (pt)
KR (1) KR20100075455A (pt)
CN (1) CN101809447A (pt)
AU (1) AU2008303540B2 (pt)
BR (1) BRPI0817310A2 (pt)
CA (1) CA2699062A1 (pt)
MX (1) MX2010003259A (pt)
RU (1) RU2010116351A (pt)
WO (1) WO2009040409A1 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8088594B2 (en) 2010-03-16 2012-01-03 Saladax Biomedical Inc. Risperidone immunoassay
US20130071835A1 (en) * 2010-05-25 2013-03-21 Nanoenteck, Inc. Qualitative and Quantitative Analytical Method for Analyzing the Activity Type of an Enzyme that is Activated by Proteolysis
CN102269850A (zh) * 2011-07-28 2011-12-07 上海上诠电信科技有限公司 光纤直接转向连接器
PL2888592T3 (pl) 2012-08-21 2018-03-30 Janssen Pharmaceutica Nv Przeciwciała względem kwetiapiny i ich zastosowania
ES2691092T3 (es) 2012-08-21 2018-11-23 Janssen Pharmaceutica Nv Anticuerpos contra la risperidona y uso de los mismos
JP6131414B2 (ja) 2012-08-21 2017-05-24 ヤンセン ファーマシューティカ エヌ.ベー. アリピプラゾールのハプテン及びイムノアッセイにおけるそれらの使用
CA2882596C (en) 2012-08-21 2019-05-14 Ortho-Clinical Diagnostics, Inc. Antibodies to olanzapine and use thereof
CN104854110B (zh) * 2012-08-21 2016-12-28 詹森药业有限公司 奥氮平半抗原
WO2014031656A1 (en) 2012-08-21 2014-02-27 Ortho-Clinical Diagnostics, Inc Antibodies to olanzapine haptens and use thereof
JP6389176B2 (ja) 2012-08-21 2018-09-12 ヤンセン ファーマシューティカ エヌ.ベー. アリピプラゾールハプテンに対する抗体及びその使用
ES2669565T3 (es) 2012-08-21 2018-05-28 Janssen Pharmaceutica Nv Haptenos de risperidona y paliperidona
CA2882562C (en) 2012-08-21 2019-08-27 Eric Hryhorenko Antibodies to aripiprazole and use thereof
JP2015527365A (ja) 2012-08-21 2015-09-17 オルソ−クリニカル ダイアグノスティクス,インコーポレイティド パリペリドンに対する抗体及びその使用
PL2888257T3 (pl) * 2012-08-21 2018-02-28 Janssen Pharmaceutica Nv Hapteny kwetiapiny do zastosowania w testach immunologicznych
JP2015529199A (ja) 2012-08-21 2015-10-05 オルソ−クリニカル ダイアグノスティクス,インコーポレイティド パリペリドンハプテンに対する抗体及びその使用
EP2888284B1 (en) 2012-08-21 2022-07-06 Janssen Pharmaceutica NV Antibodies to risperidone haptens and use thereof
CN104837838A (zh) 2012-08-21 2015-08-12 詹森药业有限公司 帕潘立酮半抗原
JP6450314B2 (ja) 2012-08-21 2019-01-09 ヤンセン ファーマシューティカ エヌ.ベー. クエチアピンハプテンに対する抗体及びその使用
BR112015009214A2 (pt) * 2012-11-07 2017-07-04 Novartis Ag derivados de indol substituído
EP3390449A1 (en) 2015-12-17 2018-10-24 Janssen Pharmaceutica N.V. Antibodies to risperidone and use thereof
US10435478B2 (en) 2015-12-17 2019-10-08 Janssen Pharmaceutica Nv Antibodies to quetiapine and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996016332A1 (en) * 1994-11-24 1996-05-30 Unipath Limited Recovery of and uses of specific binding agents
US6645970B2 (en) * 2000-11-07 2003-11-11 Novartis Ag Indolylmaleimide derivatives
EP2070921A1 (en) * 2000-11-07 2009-06-17 Novartis Ag Indolylmaleimide derivatives as protein kinase c inhibitors
AU2003214560A1 (en) * 2002-04-19 2003-11-03 Pfizer Products Inc. Test for measurement of therapeutic drug levels
WO2005088307A1 (en) 2004-03-10 2005-09-22 Seradyn Inc. Immunoassays for everolimus

Also Published As

Publication number Publication date
WO2009040409A1 (en) 2009-04-02
US8076160B2 (en) 2011-12-13
US20100216254A1 (en) 2010-08-26
AU2008303540A1 (en) 2009-04-02
EP2198309A1 (en) 2010-06-23
US20120115247A1 (en) 2012-05-10
AU2008303540B2 (en) 2012-04-26
RU2010116351A (ru) 2012-05-20
JP2010540920A (ja) 2010-12-24
US8329872B2 (en) 2012-12-11
CN101809447A (zh) 2010-08-18
MX2010003259A (es) 2010-04-12
KR20100075455A (ko) 2010-07-02
CA2699062A1 (en) 2009-04-02

Similar Documents

Publication Publication Date Title
BRPI0817310A2 (pt) Ensaio de monitoramento de fármaco
EP2260108A4 (en) PROTEASE TEST
BRPI0920521A2 (pt) combinação farmacêutica
BRPI0817927A2 (pt) Comprimidos orodispersiveis
BRPI0813707A2 (pt) Derivados de pirimidinil-piridazinona
BRPI0820112A2 (pt) Derivados de isoxazol-piridina
BRPI0818380A2 (pt) Combinação de herbicida-protetor
BRPI0809992A2 (pt) Derivados de pirrolopirimidina
BRPI0820113A2 (pt) Derivados de isoxazolo-piridazina
DE102008054533B8 (de) Ultraschallsensor
BRPI0812155A2 (pt) derivados de espiroindolinona
BRPI0817935A2 (pt) Derivados de biarila
DE602008000899D1 (de) Kraftsensor
DE112008002590A5 (de) Mikroreaktor
BRPI0814236A2 (pt) Derivados de quinazolinamida
BRPI0812518A2 (pt) Derivados de indazolamida
BRPI0820649A2 (pt) Derivados de isoxazalo-pirazina
BRPI0812916A2 (pt) Chupeta
EP2129285A4 (en) Analyte sensor
EP2156167A4 (en) BIOCHIP
DE502007004319D1 (de) Fühler
DE112008001742A5 (de) Sensoranordnung
BRPI0810559A2 (pt) Macadores de doenças
BRPI0821735A2 (pt) Fabricação de tablete
EP2172915A4 (en) Alarm

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.